Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion type Assertion NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_head.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion description "[Of the entire group, p15 and p16 alteration and positive TGF-alpha (> or =cutoff value) were significantly expressed in schistosomal bladder cancer (68.1%, 60.9%, and 65.2%), and squamous cell carcinoma type (SCC) (69.1%, 64.7% and 72.1%) compared to those with non-schistosomal bladder cancer (29.4%, 7.8%, and 37.3%) or transitional cell carcinoma (TCC) (28.8%, 3.8%, and 28.8), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_provenance.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion evidence source_evidence_literature NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_provenance.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion SIO_000772 15589816 NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_provenance.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion wasDerivedFrom befree-2016 NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_provenance.
- NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_assertion wasGeneratedBy ECO_0000203 NP472102.RApfAMTGh8Z5M6D_Q8SD8qrBEfEB40NRwbc_Ld_8PKKfY130_provenance.